当前位置: 首页 SCI 期刊 生物学 Journal Of Receptors And Signal Transduction(非官网)
Journal Of Receptors And Signal Transduction

Journal Of Receptors And Signal TransductionSCIE

国际简称:J RECEPT SIG TRANSD  参考译名:受体与信号转导

  • 中科院分区

    4区

  • CiteScore分区

    Q2

  • JCR分区

    Q3

基本信息:
ISSN:1079-9893
E-ISSN:1532-4281
是否OA:未开放
是否预警:否
TOP期刊:否
出版信息:
出版地区:UNITED STATES
出版商:Informa Healthcare
出版语言:English
出版周期:Quarterly
出版年份:1995
研究方向:生物-生化与分子生物学
评价信息:
影响因子:2.6
H-index:42
CiteScore指数:6.6
SJR指数:0.645
SNIP指数:0.582
发文数据:
Gold OA文章占比:7.58%
研究类文章占比:81.82%
年发文量:11
英文简介 期刊介绍 CiteScore数据 中科院SCI分区 JCR分区 发文数据 常见问题

英文简介Journal Of Receptors And Signal Transduction期刊介绍

Journal of Receptors and Signal Transduction is a prestigious academic journal that focuses on reporting the latest research findings on biological receptors and their related signal transduction pathways. This journal covers a wide range of fields, including various types of ligands such as neurotransmitters, peptides, steroids, growth factors, cytokines, and drugs, as well as their mechanisms of action in regulating central and peripheral tissues and cells (including the immune system).

Magazines are favored by the international scientific community for their rapid dissemination of important research results. This journal adopts various forms of articles, including original papers, review papers, brief communications, solicited and non solicited small comments, and seminar proceedings, to meet the needs of different readers. Through these articles, readers can stay up-to-date with the latest developments and research trends in the field. It is of great significance in promoting academic research and clinical applications in related fields. It provides a platform for scholars to communicate and discuss, promoting cross disciplinary cooperation and innovation between different fields. At the same time, the research findings of this journal also provide new treatment ideas and methods for clinical medicine, which can help improve the health status of patients.

期刊简介Journal Of Receptors And Signal Transduction期刊介绍

《Journal Of Receptors And Signal Transduction》自1995出版以来,是一本生物学优秀杂志。致力于发表原创科学研究结果,并为生物学各个领域的原创研究提供一个展示平台,以促进生物学领域的的进步。该刊鼓励先进的、清晰的阐述,从广泛的视角提供当前感兴趣的研究主题的新见解,或审查多年来某个重要领域的所有重要发展。该期刊特色在于及时报道生物学领域的最新进展和新发现新突破等。该刊近一年未被列入预警期刊名单,目前已被权威数据库SCIE收录,得到了广泛的认可。

该期刊投稿重要关注点:

Cite Score数据(2024年最新版)Journal Of Receptors And Signal Transduction Cite Score数据

  • CiteScore:6.6
  • SJR:0.645
  • SNIP:0.582
学科类别 分区 排名 百分位
大类:Biochemistry, Genetics and Molecular Biology 小类:Biochemistry Q2 158 / 438

64%

大类:Biochemistry, Genetics and Molecular Biology 小类:Molecular Biology Q2 178 / 410

56%

大类:Biochemistry, Genetics and Molecular Biology 小类:Cell Biology Q2 135 / 285

52%

CiteScore 是由Elsevier(爱思唯尔)推出的另一种评价期刊影响力的文献计量指标。反映出一家期刊近期发表论文的年篇均引用次数。CiteScore以Scopus数据库中收集的引文为基础,针对的是前四年发表的论文的引文。CiteScore的意义在于,它可以为学术界提供一种新的、更全面、更客观地评价期刊影响力的方法,而不仅仅是通过影响因子(IF)这一单一指标来评价。

历年Cite Score趋势图

中科院SCI分区Journal Of Receptors And Signal Transduction 中科院分区

中科院 2023年12月升级版 综述期刊:否 Top期刊:否
大类学科 分区 小类学科 分区
生物学 4区 BIOCHEMISTRY & MOLECULAR BIOLOGY 生化与分子生物学 CELL BIOLOGY 细胞生物学 4区 4区

中科院分区表 是以客观数据为基础,运用科学计量学方法对国际、国内学术期刊依据影响力进行等级划分的期刊评价标准。它为我国科研、教育机构的管理人员、科研工作者提供了一份评价国际学术期刊影响力的参考数据,得到了全国各地高校、科研机构的广泛认可。

中科院分区表 将所有期刊按照一定指标划分为1区、2区、3区、4区四个层次,类似于“优、良、及格”等。最开始,这个分区只是为了方便图书管理及图书情报领域的研究和期刊评估。之后中科院分区逐步发展成为了一种评价学术期刊质量的重要工具。

历年中科院分区趋势图

JCR分区Journal Of Receptors And Signal Transduction JCR分区

2023-2024 年最新版
按JIF指标学科分区 收录子集 分区 排名 百分位
学科:BIOCHEMISTRY & MOLECULAR BIOLOGY SCIE Q3 204 / 313

35%

学科:CELL BIOLOGY SCIE Q3 144 / 205

30%

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:BIOCHEMISTRY & MOLECULAR BIOLOGY SCIE Q4 255 / 313

18.69%

学科:CELL BIOLOGY SCIE Q4 162 / 205

21.22%

JCR分区的优势在于它可以帮助读者对学术文献质量进行评估。不同学科的文章引用量可能存在较大的差异,此时单独依靠影响因子(IF)评价期刊的质量可能是存在一定问题的。因此,JCR将期刊按照学科门类和影响因子分为不同的分区,这样读者可以根据自己的研究领域和需求选择合适的期刊。

历年影响因子趋势图

本刊中国学者近年发表论文

  • 1、Therapeutic effect of CNP on renal osteodystrophy by antagonizing the FGF-23/MAPK pathway.

    Author: Hu P, Huang BY, Xia X, Xuan Q, Hu B, Qin YH.

    Journal: J Recept Signal Transduct Res. 2016;36(2):213-9. doi: 10.3109/10799893.2015.1075041. Epub 2015 Oct 13.

  • 2、The emerging role of hepatocyte growth factor in renal diseases.

    Author: Mao S, Zhang J.

    Journal: J Recept Signal Transduct Res. 2016;36(3):303-9. doi: 10.3109/10799893.2015.1080275. Epub 2015 Oct 13.

  • 3、Activation of ERK pathway is required for 15-HETE-induced angiogenesis in human umbilical vascular endothelial cells.

    Author: Wang S, Cao W, Xing H, Chen YL, Li Q, Shen T, Jiang C, Zhu D.

    Journal: J Recept Signal Transduct Res. 2016;36(3):225-32. doi: 10.3109/10799893.2015.1077865. Epub 2015 Oct 13.

  • 4、Effect of the co-culture of human bone marrow mesenchymal stromal cells with human umbilical vein endothelial cells in vitro.

    Author: Lin Q, Wang L, Bai Y, Hu M, Mo J, He H, Lou A, Yang B, Zhao H, Guo Y, Wu Y, Wang L.

    Journal: J Recept Signal Transduct Res. 2016;36(3):221-4. doi: 10.3109/10799893.2015.1075043. Epub 2015 Oct 19.

  • 5、GPR39 activates proliferation and differentiation of porcine intramuscular preadipocytes through targeting the PI3K/AKT cell signaling pathway.

    Author: Dong X, Tang S, Zhang W, Gao W, Chen Y.

    Journal: J Recept Signal Transduct Res. 2016;36(2):130-8. doi: 10.3109/10799893.2015.1056308. Epub 2015 Nov 2.

  • 6、CD2-associated protein participates in podocyte apoptosis via PI3K/Akt signaling pathway.

    Author: Ren Q, You Yu S.

    Journal: J Recept Signal Transduct Res. 2016;36(3):288-91. doi: 10.3109/10799893.2015.1101137. Epub 2015 Nov 20.

  • 7、High glucose induces rat mesangial cells proliferation and MCP-1 expression via ROS-mediated activation of NF-κB pathway, which is inhibited by eleutheroside E.

    Author: Yang X, Wang Y, Gao G.

    Journal: J Recept Signal Transduct Res. 2016;36(2):152-7. doi: 10.3109/10799893.2015.1061002. Epub 2015 Dec 7.

  • 8、JNK pathway in osteosarcoma: pathogenesis and therapeutics.

    Author: Li YS, Deng ZH, Zeng C, Lei GH.

    Journal: J Recept Signal Transduct Res. 2016 Oct;36(5):465-70. doi: 10.3109/10799893.2015.1122045. Epub 2015 Dec 16.

投稿常见问题

通讯方式:TAYLOR & FRANCIS INC, 325 CHESTNUT ST, SUITE 800, PHILADELPHIA, USA, PA, 19106。